West Pharmaceutical Services Deferred Compensation Liability, Classified, Noncurrent decreased by 12.6% to $11.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.5%, from $11.40M to $11.80M. Over 5 years (FY 2020 to FY 2025), Deferred Compensation Liability, Classified, Noncurrent shows a downward trend with a -10.0% CAGR.
other_deferred_compensation_liability_classified_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.70M | $26.90M | $28.90M | $26.30M | $21.40M | $19.20M | $19.10M | $19.00M | $20.60M | $17.90M | $18.60M | $18.60M | $15.50M | $15.20M | $15.40M | $11.40M | $12.50M | $13.50M | $13.50M | $11.80M |
| QoQ Change | — | +8.9% | +7.4% | -9.0% | -18.6% | -10.3% | -0.5% | -0.5% | +8.4% | -13.1% | +3.9% | +0.0% | -16.7% | -1.9% | +1.3% | -26.0% | +9.6% | +8.0% | +0.0% | -12.6% |
| YoY Change | — | — | — | — | -13.4% | -28.6% | -33.9% | -27.8% | -3.7% | -6.8% | -2.6% | -2.1% | -24.8% | -15.1% | -17.2% | -38.7% | -19.4% | -11.2% | -12.3% | +3.5% |